BackgroundThere are inconsistent and limited data regarding the risk of myeloid neoplasms (MN) among breast cancer survivors who received radiotherapy (RT) in the absence of chemotherapy. Concern abou
BackgroundChimeric antigen receptor (CAR) T-cell therapy has emerged as a novel treatment modality for hematologic malignancies and is predicted to experience widespread use in the near future. Howeve
AbstractBackground & Aims: Individuals negative for hepatitis B virus (HBV) surface antigen (HBsAg) but positive for antibodies against the hepatitis B core antigen (HBc) are at risk of de novo HBV re
